Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

sagi habasov

840 POSTS

Exclusive articles:

SKN | Dianthus Therapeutics (DNTH) Stock Climbs Over 10% as Investors Continue to Back Autoimmune Disease Pipeline

Dianthus Therapeutics (NASDAQ: DNTH) posted another strong trading session, with shares rising 10.75% to $105.60. The stock continued its positive momentum in after-hours trading,...

SKN | Latigo Biotherapeutics Files for $100 Million IPO to Advance Non-Opioid Pain Treatment Pipeline

Latigo Biotherapeutics has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO) that could raise up to $100...

SKN | BlossomHill Therapeutics Files for $100 Million IPO to Advance Next-Generation Cancer Drug Pipeline

BlossomHill Therapeutics has filed for an initial public offering (IPO) seeking to raise up to $100 million as it advances a pipeline of small...

SKN | ManpowerGroup Shares Surge 32% After Earnings Beat and Improved Outlook

Shares of ManpowerGroup Inc. (NYSE: MAN) jumped 32.37% to close at $51.65, marking one of the company's strongest single-session gains in recent years after...

SKN | Disciplined Growth Acquisition Corp. Targets IPO as SPAC Market Seeks Higher-Quality Deal Flow

Disciplined Growth Acquisition Corporation is preparing for its initial public offering, aiming to raise capital through a special purpose acquisition company (SPAC) structure that...

Breaking

SKN | Viking Acquisition Corp. II Advances SPAC IPO Plans as Investors Evaluate New Market Opportunities

Viking Acquisition Corp. II is preparing for its public...

SKN | Goldgroup Mining Inc. Positions for Public Market Growth as Investors Monitor Mining Sector Opportunities

Goldgroup Mining Inc. is attracting attention from investors as...

SKN | Oruka Therapeutics Extends Rally as Investors Bet on Autoimmune Pipeline Ahead of August Catalyst

Oruka Therapeutics (NASDAQ: ORKA) closed at $92.70, gaining $9.66...

SKN | Dianthus Therapeutics (DNTH) Stock Climbs Over 10% as Investors Continue to Back Autoimmune Disease Pipeline

Dianthus Therapeutics (NASDAQ: DNTH) posted another strong trading session,...
spot_imgspot_img